July 17, 2025

FDA Approves Shingrix Prefilled Syringe Option

The FDA has approved a new prefilled syringe presentation of Shingrix to simplify herpes zoster vaccination for eligible adult patients.

Conexiant

June 30, 2025

Breakthrough Device Approvals Outpacing Data

Many FDA-authorized breakthrough therapeutic devices may lack robust clinical testing.

Conexiant

June 23, 2025

Older Adults Lead Vaccine Comeback

Older Americans are embracing vaccines—backed by new research confirming enhanced safety, disease prevention, and even a potential link to reduced dementia risk.

KFF Health News

December 11, 2024

ALS Drug Misses Trial Goals

A mid-stage trial for an experimental drug in ALS patients did not meet its main goal, with patients showing more gastrointestinal upset compared to a placebo, and differing death rates between groups. Results will be presented next year, and a long-term extension study will continue.

Reuters

April 29, 2024

Exposed to Agent Orange at US Bases, Veterans Face Cancer Without VA Compensation

A veteran's struggle for recognition of health issues linked to exposure to a controversial herbicide used by the military.

KFF Health News

April 29, 2024

Record Heat Waves Propel Surge in Heat-Related Illness

2023 brought record-breaking heat waves in the United States, significantly impacting vulnerable groups. Analysis by the CDC revealed a substantial number of heat-related illness (HRI) emergency department visits, resulting in multiple public health alerts.

Conexiant

May 27, 2025

FDA Approves Infant Use of MenQuadfi

MenQuadfi becomes the first meningococcal vaccine approved for infants as young as 6 weeks.

Reuters

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

July 26, 2024

16 U.S. States Reach $86M Settlement with Drug Manufacturer

Indivior, a Virginia-based drug manufacturer, has reached an $86 million settlement with 16 U.S. states over its alleged role in the opioid addiction crisis, involving buprenorphine-based products. The settlement funds will be used for opioid addiction treatment, recovery, and prevention.

Reuters